{"id":"https://openalex.org/W2584580415","doi":"https://doi.org/10.1021/acs.jmedchem.6b01751","title":"Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases","display_name":"Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases","publication_year":2017,"publication_date":"2017-02-02","ids":{"openalex":"https://openalex.org/W2584580415","doi":"https://doi.org/10.1021/acs.jmedchem.6b01751","mag":"2584580415","pmid":"https://pubmed.ncbi.nlm.nih.gov/28151659"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6b01751","doi":"https://doi.org/10.1021/acs.jmedchem.6b01751","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b01751","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038108029","display_name":"Philip A. Harris","orcid":"https://orcid.org/0000-0002-5189-3326","observed_orcids":["https://orcid.org/0000-0002-5189-3326"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Philip A. Harris","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":"https://orcid.org/0000-0002-5189-3326","affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103820624","display_name":"Scott B. Berger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott B. Berger","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111205486","display_name":"Jae Uk Jeong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae U. Jeong","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037055416","display_name":"Rakesh Nagilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rakesh Nagilla","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052974651","display_name":"Deepak Bandyopadhyay","orcid":"https://orcid.org/0000-0002-8747-369X","observed_orcids":["https://orcid.org/0000-0002-8747-369X"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Deepak Bandyopadhyay","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050234899","display_name":"Nino Campobasso","orcid":"https://orcid.org/0000-0003-3419-2840","observed_orcids":["https://orcid.org/0000-0003-3419-2840"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Nino Campobasso","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110986719","display_name":"Carol A. Capriotti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol A. Capriotti","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031037222","display_name":"Julie A. Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Julie A. Cox","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055694463","display_name":"Lauren C. Dare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lauren Dare","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082373186","display_name":"Xiaoyang Dong","orcid":"https://orcid.org/0000-0002-0663-1482","observed_orcids":["https://orcid.org/0000-0002-0663-1482"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyang Dong","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011706264","display_name":"Patrick M. Eidam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick M. Eidam","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030755398","display_name":"Joshua N. Finger","orcid":"https://orcid.org/0000-0003-3240-9778","observed_orcids":["https://orcid.org/0000-0003-3240-9778"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua N. Finger","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111827790","display_name":"Sandra J. Hoffman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra J. Hoffman","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105989918","display_name":"James J. Kang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Kang","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033825403","display_name":"Viera Kasparcova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viera Kasparcova","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109369728","display_name":"Bryan W. King","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Bryan W. King","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010855293","display_name":"Ruth V. Lehr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Ruth Lehr","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046095592","display_name":"Yunfeng Lan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunfeng Lan","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112431963","display_name":"Lara K. Leister","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lara K. Leister","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049284362","display_name":"John D. Lich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Lich","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103441994","display_name":"Thomas Thornton MacDonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas T. MacDonald","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute,\rBarts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute,\rBarts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111642240","display_name":"Nathan A. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathan A. Miller","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064482514","display_name":"Michael T. Ouellette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Michael T. Ouellette","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102794709","display_name":"Christina S. Pao","orcid":"https://orcid.org/0000-0001-7415-1803","observed_orcids":["https://orcid.org/0000-0001-7415-1803"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Christina S. Pao","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Attiq Rahman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Attiq Rahman","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083068484","display_name":"Michael Reilly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Reilly","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002519621","display_name":"Alan R. Rendina","orcid":"https://orcid.org/0009-0003-9309-9651","observed_orcids":["https://orcid.org/0009-0003-9309-9651"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Alan R. Rendina","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050983216","display_name":"Elizabeth J. Rivera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Rivera","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047985010","display_name":"Michelle C. Schaeffer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Michelle C. Schaeffer","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006516121","display_name":"Clark A. Sehon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clark A. Sehon","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090493929","display_name":"Robert R. Singhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert R. Singhaus","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077276567","display_name":"Helen H. Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen H. Sun","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112172994","display_name":"Barbara A. Swift","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara A. Swift","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071752056","display_name":"Rachel D. Totoritis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Rachel D. Totoritis","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016644184","display_name":"Anna Vossenk\u00e4mper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Vossenk\u00e4mper","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute,\rBarts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute,\rBarts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003893325","display_name":"Paris Ward","orcid":"https://orcid.org/0000-0002-6253-0379","observed_orcids":["https://orcid.org/0000-0002-6253-0379"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Paris Ward","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019782219","display_name":"David D. Wisnoski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"David D. Wisnoski","raw_affiliation_strings":["Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immunobiology, Blizard Institute, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London, E1 2AD London, U.K","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]},{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109423358","display_name":"Daohua Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daohua Zhang","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109720987","display_name":"Robert W. Marquis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert W. Marquis","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085773542","display_name":"Peter J. Gough","orcid":"https://orcid.org/0000-0002-5110-9300","observed_orcids":["https://orcid.org/0000-0002-5110-9300"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J. Gough","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009373772","display_name":"John Bertin","orcid":"https://orcid.org/0000-0001-9048-1650","observed_orcids":["https://orcid.org/0000-0001-9048-1650"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Bertin","raw_affiliation_strings":["\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020 Pattern Recognition Receptor DPU and \u2021 Platform Technology & Science, GlaxoSmithKline, Collegeville Road, Collegeville, Pennsylvania 19426, United States","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038108029"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":509,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"60","issue":"4","first_page":"1247","last_page":"1261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4706999957561493,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.4706999957561493,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.08760000020265579,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.08749999850988388,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rip1-kinase","display_name":"RIP1 kinase","score":0.9049999713897705},{"id":"https://openalex.org/keywords/necroptosis","display_name":"necroptosis","score":0.8999999761581421},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.6349999904632568},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.5860000252723694},{"id":"https://openalex.org/keywords/dna-encoded-libraries","display_name":"DNA-encoded libraries","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tnf-signaling","display_name":"TNF signaling","score":0.6169999837875366},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.8769999742507935},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":1.0},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.6840000152587891},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6048243045806885},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.5819110870361328},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5624602437019348},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5430296659469604},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5399413704872131},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.5211089253425598},{"id":"https://openalex.org/C94030615","wikidata":"https://www.wikidata.org/wiki/Q3346925","display_name":"Necroptosis","level":4,"score":0.5005433559417725},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.48812517523765564},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45931723713874817},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.45114749670028687},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4135655164718628},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4110843241214752},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38407641649246216},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34018951654434204},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28815245628356934},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18343129754066467},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13813018798828125},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.11340802907943726},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.09199678897857666},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0911858081817627},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003093","descriptor_name":"Colitis, Ulcerative","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013556","descriptor_name":"Swine, Miniature","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053422","descriptor_name":"Receptor-Interacting Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053422","descriptor_name":"Receptor-Interacting Protein Serine-Threonine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.6b01751","doi":"https://doi.org/10.1021/acs.jmedchem.6b01751","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b01751","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:28151659","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28151659","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/39609","doi":null,"is_oa":false,"landing_page_url":"http://qmro.qmul.ac.uk/xmlui/handle/123456789/39609","pdf_url":null,"source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1776031695","https://openalex.org/W1968023901","https://openalex.org/W1968753037","https://openalex.org/W1970990504","https://openalex.org/W1973734061","https://openalex.org/W1981237612","https://openalex.org/W1985231277","https://openalex.org/W1985831101","https://openalex.org/W1986320887","https://openalex.org/W1988848002","https://openalex.org/W2005138952","https://openalex.org/W2005928313","https://openalex.org/W2010354804","https://openalex.org/W2010766264","https://openalex.org/W2030479855","https://openalex.org/W2033968700","https://openalex.org/W2056328506","https://openalex.org/W2072540607","https://openalex.org/W2086665516","https://openalex.org/W2091389437","https://openalex.org/W2110796758","https://openalex.org/W2128756078","https://openalex.org/W2158662692","https://openalex.org/W2164482565","https://openalex.org/W2165158819","https://openalex.org/W2189824412","https://openalex.org/W2280294408","https://openalex.org/W2411565536","https://openalex.org/W2467178923","https://openalex.org/W4301490812"],"related_works":["https://openalex.org/W7165665394","https://openalex.org/W4252067953","https://openalex.org/W4408749691","https://openalex.org/W2280294408","https://openalex.org/W2561251264","https://openalex.org/W4416424960","https://openalex.org/W4400204615","https://openalex.org/W3043787135","https://openalex.org/W4200429961","https://openalex.org/W2411565536"],"abstract_inverted_index":{"RIP1":[0,26,84],"regulates":[1],"necroptosis":[2],"and":[3,5,55,58,76,89,127],"inflammation":[4],"may":[6],"play":[7],"an":[8],"important":[9],"role":[10],"in":[11,67,93,143],"contributing":[12],"to":[13,38,83,112,137],"a":[14,48,52,103,138],"variety":[15],"of":[16,25,47,60,116,130],"human":[17,119],"pathologies,":[18],"including":[19],"immune-mediated":[20],"inflammatory":[21],"diseases.":[22],"Small-molecule":[23],"inhibitors":[24],"kinase":[27,87],"that":[28],"are":[29],"suitable":[30],"for":[31,72],"advancement":[32],"into":[33],"the":[34,56,107],"clinic":[35],"have":[36],"yet":[37],"be":[39],"described.":[40],"Herein,":[41],"we":[42],"report":[43],"our":[44],"lead":[45],"optimization":[46],"benzoxazepinone":[49],"hit":[50],"from":[51,118],"DNA-encoded":[53],"library":[54],"discovery":[57],"profile":[59],"clinical":[61,70],"candidate":[62],"GSK2982772":[63],"(compound":[64],"5),":[65],"currently":[66],"phase":[68],"2a":[69],"studies":[71],"psoriasis,":[73],"rheumatoid":[74],"arthritis,":[75],"ulcerative":[77,120],"colitis.":[78],"Compound":[79],"5":[80],"potently":[81],"binds":[82],"with":[85,133],"exquisite":[86],"specificity":[88],"has":[90],"excellent":[91],"activity":[92],"blocking":[94],"many":[95],"TNF-dependent":[96],"cellular":[97],"responses.":[98],"Highlighting":[99],"its":[100],"potential":[101],"as":[102],"novel":[104],"anti-inflammatory":[105],"agent,":[106],"inhibitor":[108],"was":[109],"also":[110],"able":[111],"reduce":[113],"spontaneous":[114],"production":[115],"cytokines":[117],"colitis":[121],"explants.":[122],"The":[123],"highly":[124],"favorable":[125],"physicochemical":[126],"ADMET":[128],"properties":[129],"5,":[131],"combined":[132],"high":[134],"potency,":[135],"led":[136],"predicted":[139],"low":[140],"oral":[141],"dose":[142],"humans.":[144]},"counts_by_year":[{"year":2026,"cited_by_count":41},{"year":2025,"cited_by_count":60},{"year":2024,"cited_by_count":60},{"year":2023,"cited_by_count":64},{"year":2022,"cited_by_count":59},{"year":2021,"cited_by_count":67},{"year":2020,"cited_by_count":52},{"year":2019,"cited_by_count":46},{"year":2018,"cited_by_count":43},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2017-02-10T00:00:00"}